KalVista Pharmaceuticals, Inc. has announced the granting of inducement stock options to five newly-hired employees as part of their compensation package. These options allow the purchase of a total of 23,000 shares of the company's common stock, effective from July 1, 2025. The exercise price for these options is set at the closing price of KalVista's stock on the grant date. The vesting schedule includes one-fourth of the options becoming available one year from the vesting commencement date, with the remaining options vesting in equal monthly installments over the following three years, contingent upon continued employment. Each option has a 10-year term and adheres to the guidelines of KalVista's Inducement Equity Incentive Plan. These grants were made under Nasdaq Listing Rule 5635(c)(4).
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。